Canada markets open in 41 minutes

Evofem Biosciences, Inc. (EVFM)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0350-0.0015 (-4.11%)
At close: 03:59PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2021-12-31
2020-12-31
2019-12-31
Total Revenue
20,226
8,244
446
0
Cost of Revenue
5,786
4,055
468
-
Gross Profit
14,440
4,189
-22
-
Operating Expenses
Research Development
32,001
33,129
17,050
22,230
Selling General and Administrative
91,929
137,861
86,552
30,512
Total Operating Expenses
123,930
170,990
103,602
52,742
Operating Income or Loss
-109,490
-166,801
-103,624
-52,742
Total Other Income/Expenses Net
-10,440
-38,389
-38,850
-27,745
Income Before Tax
-119,874
-205,175
-142,305
-80,029
Income Tax Expense
42
17
4
4
Income from Continuing Operations
-119,916
-205,192
-142,309
-80,033
Net Income
-119,916
-205,192
-142,309
-80,033
Net Income available to common shareholders
-119,136
-206,239
-142,309
-80,033
Basic EPS
-
-23.70
-31.80
-29.85
Diluted EPS
-
-23.70
-31.80
-29.85
Basic Average Shares
-
8,727
4,477
2,682
Diluted Average Shares
-
8,727
4,477
2,682
EBITDA
-
-165,778
-103,322
-52,479